Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2012-02, Vol.156 (3), p.402-404
Hauptverfasser:	Haskova, Zdenka, Whitacre, Margaret N., Dede, Kimberly A., Lee, Judithann M., Trulli, Stephen H., Ciucci, Marc, Toso, John F., White, John R., Jonak, Zdenka L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal, Murine-Derived - pharmacology Antigens, CD20 - immunology Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use bendamustine Bendamustine Hydrochloride Biological and medical sciences Cell Line, Tumor - drug effects Cell Line, Tumor - transplantation chronic lymphocytic leukaemia combination therapy Female Hematologic and hematopoietic diseases Humans Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Mice Mice, SCID Nitrogen Mustard Compounds - administration & dosage Nitrogen Mustard Compounds - pharmacology Ofatumumab Rituximab Tumor Burden - drug effects tumour xenograft Xenograft Model Antitumor Assays
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!